The Phase II clinical trial of FX06 (Fire study) in 234 patients with acute myocardial infarcts was completed in March 2008, with data indicating a statistically significant reduction
Mr Ueda will be responsible for licensing and commercialization activities in the Asia-Pacific area, including Japan. Mr Ueda graduated from the School of Pharmaceutical Sciences, Kyoto University. Mr
Cytovance Biologics has completed the process transfer and scale-up to 100L of a fed-batch bioreactor production process using Invitrogen’s new CD OptiCHO medium and CHO CD EfficientFeed supplement
Mr Tanaka is newly retired from Biosense Webster, a Johnson & Johnson company, where he most recently served as worldwide president. Mr Tanaka has received a bachelor of
In addition to his financial responsibilities, Mr Jacobson will be accountable for Ricerca’s legal, human resources, facilities and IT functions. Prior to joining Ricerca, Mr Jacobson was the
As part of the overall understanding between the parties, Antares will be responsible for development and commercial manufacturing of the product and Dr Reddy’s will be responsible for
Discovered by Osi’s diabetes and obesity research team, PSN821 demonstrated both effective glucose lowering and substantial reductions of body weight in pre-clinical studies. PSN821 is said to be
The complaint alleges that Maquet’s Vasoview endoscopic vessel harvesting systems infringe a patent for which Terumo owns the rights. The complaint also requests an injunction against further sales
Endo Pharmaceuticals has engaged an executive search firm to assist in the search for a new CFO. David Holveck, president and CEO of Endo Pharmaceuticals, said: “The board
With respect to the ongoing development of atacicept, an investigational drug for the treatment of various autoimmune diseases and B-cell malignancies, ZymoGenetics has exercised its contractual right to
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.